Company Monitoring Page for Esperion-Therapeutics

@TheRoaringKitty t.co/Xu8BzyuY3v

@elonmusk t.co/Xu8BzyuY3v

@TheRoaringKitty t.co/Xu8BzyuY3v

RT @DavidVGoliath6: $ESPR $134 price target today, 38% short interest, over 112% institutional ownership, first in class drug with blockbus…

$ESPR $134 price target today, 38% short interest, over 112% institutional ownership, first in class drug with bloc… t.co/3yKP2X0XHb

RT @DavidVGoliath6: #ShortSqueeze continuing! @wallstreetbets @redditinvestors @watchoutshorts $GME $AMC $KOSS and the gem $ESPR with 38…

#ShortSqueeze continuing! @wallstreetbets @redditinvestors @watchoutshorts $GME $AMC $KOSS and the gem $ESPR wit… t.co/G32AUpqSc5

@realwillmeade $ESPR close to 40% short also also and huge potential, why no attention?🆘 t.co/Xld0PoagxH… t.co/W0NJUlQ837

@haodongvli Agreed bio is ready! $ESPR de-risked and ready to pop! @wallstreetbets @watchoutshorts @MarketRebels… t.co/rebZ0AdWiy

RT @DavidVGoliath6: Plenty to chose from$ESPR✔️ $AMC $GME $GOGO, $CLVS, $SENS, $ESPR, $KOSS, $GME, $HUYA, $BLNK, $FLGT, $PGEN, $OPK, $CLR…

RT @DavidVGoliath6: @cvpayne SI % Float $GOGO, $CLVS, $SENS, $ESPR, $KOSS, $GME, $HUYA, $BLNK, $FLGT, $PGEN, $OPK, $CLR, $BGS, $AMCX, $VTVT…

RT @DavidVGoliath6: @ryanmastro5 SI % Float $GOGO, $CLVS, $SENS, $ESPR, $KOSS, $GME, $HUYA, $BLNK, $FLGT, $PGEN, $OPK, $CLR, $BGS, $AMCX, $…

Plenty to chose from$ESPR✔️ $AMC $GME $GOGO, $CLVS, $SENS, $ESPR, $KOSS, $GME, $HUYA, $BLNK, $FLGT, $PGEN, $OPK,… t.co/dB1MRF0YOG

@cvpayne SI % Float $GOGO, $CLVS, $SENS, $ESPR, $KOSS, $GME, $HUYA, $BLNK, $FLGT, $PGEN, $OPK, $CLR, $BGS, $AMCX,… t.co/zV0LVYXaCz

@ryanmastro5 SI % Float $GOGO, $CLVS, $SENS, $ESPR, $KOSS, $GME, $HUYA, $BLNK, $FLGT, $PGEN, $OPK, $CLR, $BGS,… t.co/6iahllF4u5

@GolferOptions It’s a gem as you know! Let’s get more than 22% like the last time that $GME $AMC were flying… t.co/7ArC45mds6

@intel_options All@good candidates! $ESPR is my favorite! t.co/Xld0PoagxH t.co/heCEkqMle9 t.co/i06rdPbJbr

@semodough And where do you think it’s headed? Many think it will recover well this year if it’s not bought out fir… t.co/KLCHL9DJqU

Esperion Therapeutics, Inc current quarter revenue growth YoY of 290.70% ranked 91 out of 5489 companies in our dat… t.co/IPdgP3nOR6

Top shorted stocks and of course $GME & $AMC are on the list but how do the bios like $ESPR & $CLVS continue to go… t.co/W6Wpcx6li8

@MotherCabriniNY @_Zenil_ @dapstats He really was involved with that suit, I know you don’t like the stock but plen… t.co/A0jx6qeiX1

@_Zenil_ @realwillmeade Yes $ESPR also!!! So undervalued and over shorted also. t.co/Xld0PoagxH… t.co/mMILKAt16v

@VietHeartPA @CBDiekman Thank you for the information on improve it, I’m finding a lot of good information on this… t.co/d5dJf9WUlJ

@ReduxGFX @unusual_whales $ESPR is also a BO candidate and this article calls the biotech de-risked!!… t.co/husifaEIZL

RT @SeekingAlpha: $ESPR - Esperion Therapeutics, Inc. (ESPR) CEO Timothy Mayleben on Q4 2020 Results - Earnings Call Transcript. t.…

@unusual_whales $ESPR 67% short interest t.co/zm9EnisFhh

/6 This case ("Dougherty v. Esperion Therapeutics, Inc.") has legs and is discussed in some detail in the recently-… t.co/EH7gh4blwx